Barclays’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-119,500
Closed -$7.21M 7122
2016
Q2
$7.21M Buy
119,500
+100,900
+542% +$5.72M 0.01% 1051
2016
Q1
$837K Sell
18,600
-34,200
-65% -$1.24M ﹤0.01% 2686
2015
Q4
$2.54M Sell
52,800
-40,500
-43% -$1.75M ﹤0.01% 1839
2015
Q3
$3.92M Buy
93,300
+59,500
+176% +$2.95M ﹤0.01% 1535
2015
Q2
$1.93M Sell
33,800
-65,200
-66% -$4.02M ﹤0.01% 2252
2015
Q1
$6.38M Buy
99,000
+51,800
+110% +$2.97M 0.01% 1379
2014
Q4
$2.34M Sell
47,200
-55,400
-54% -$2.88M ﹤0.01% 2388
2014
Q3
$5.03M Buy
102,600
+63,200
+160% +$2.69M ﹤0.01% 1770
2014
Q2
$1.52M Sell
39,400
-319,400
-89% -$10.8M ﹤0.01% 2894
2014
Q1
$11.5M Buy
358,800
+286,200
+394% +$10.6M 0.01% 1049
2013
Q4
$2.29M Sell
72,600
-46,600
-39% -$1.41M ﹤0.01% 2530
2013
Q3
$3.52M Buy
119,200
+83,600
+235% +$2.39M ﹤0.01% 2007
2013
Q2
$876K Buy
+35,600
New +$896K ﹤0.01% 3556

Other funds holding MDVN

Barclays's MDVN Position: Q3 2016 in Review

Barclays sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 198,801 shares — an estimated $12M sold.

Barclays first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $12M in Q2 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Barclays reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Barclays sold 198,801 MEDIVATION, INC. shares in Q3 2016, an estimated $12M.
  • Barclays first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • Barclays's MEDIVATION, INC. position peaked at $12M in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.